SBI Securities’s Inozyme Pharma INZY Stock Holding History

SBI Securities’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-34	Closed	-$136	–	4251
2025 Q2	$136	Hold	34	–	–	﹤0.01%	3436
2025 Q1	$31	Hold	34	–	–	﹤0.01%	3762
2024 Q4	$94	Buy	+34	New	+$129	﹤0.01%	3474

SBI Securities's INZY Position: Q3 2025 in Review

SBI Securities sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 34 shares — an estimated $136 sold.

SBI Securities first reported a position in INZY in Q4 2024 and held it in 3 quarters. The position peaked at $136 in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

SBI Securities reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
SBI Securities sold 34 Inozyme Pharma shares in Q3 2025, an estimated $136.
SBI Securities first reported a position in Inozyme Pharma in Q4 2024 and held it in 3 quarters.
SBI Securities's Inozyme Pharma position peaked at $136 in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.